Cited by 888Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Diabetic dyslipidaemia: from basic research to clinical practice*

Open access

Taskinen, M.-R.·2003·Diabetologia

DOI 10.1007/s00125-003-1111-y

Open this paper in CoChat — free account Open PDF

Abstract

The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is associated with multiple alterations of other lipoproteins species that are potentially atherogenic has expanded the picture of diabetic dyslipidaemia. The discovery of heterogeneity within major lipoprotein classes VLDL, LDL and HDL opened new avenues to reveal the specific pertubations of diabetic dyslipidaemia. The increase of large VLDL 1 particles in Type 2 diabetes initiates a sequence of events that generates atherogenic remnants, small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase of VLDL 1 particles in diabetic dyslipidaemia? Despite the advances of recent years, our understanding of VLDL assembly and secretion is still surprisingly incomplete. To date it is still unclear how the liver is able to regulate the amount of triglycerides incorporated into VLDL particles to produce either VLDL 1 or VLDL 2 particles. The current evidence suggests that the machinery driving VLDL assembly in the liver includes (i) low insulin signalling via PI-3 kinase pathway that enhances lipid accumulation into "nascent " VLDL particles (ii) up-regulation of SREBP-1C that stimulates de novo lipogenesis and (iii) excess availability of "polar molecules" in hepatocytes that stabilizes apo B 100. Recent data suggest that all these steps could be fundamentally altered in Type 2 diabetes explaining the overproduction of VLDL apo B as well as the ability of insulin to suppress VLDL 1 apo B production in Type 2 diabetes. Recent discoveries have established the transcription factors including PPARs, SREBP-1 and LXRs as the key regulators of lipid assembly in the liver. These observations suggest these factors as a new target to tailor more efficient drugs to treat diabetic dyslipidaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1111-y

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Self-citation
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014

Show all 183 references

Sorted by citations

Items 401–500 of 885

Effects of Rosiglitazone on Fasting and Postprandial Low- and High-Density Lipoproteins Size and Subclasses in Type 2 Diabetes
Rizzo, M., Vekić, J., Koulouris, S. N., Zeljković, A., Jelić‐Ivanović, Z., Spasojević‐Kalimanovska, V., Rini, G. B., Sakellariou, D., Pastromas, S. C., Mikhailidis, D. P., et al. (2010) · Angiology · doi:10.1177/0003319710366431 · Cited by 19
Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes
Dullaart, R. P. F., de Vries, R., Kwakernaak, A. J., Perton, F. G., & Dallinga‐Thie, G. M. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12377 · Cited by 19
Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes
Johansen, R. F., Søndergaard, E., Sørensen, L. P., Jurik, A. G., Christiansen, J. S., & Nielsen, S. (2016) · Diabetologia · doi:10.1007/s00125-015-3856-5 · Cited by 19
Acute Effect of Metformin on Postprandial Hypertriglyceridemia through Delayed Gastric Emptying
Sato, D., Morino, K., Nakagawa, F., Murata, K., Sekine, O., Beppu, F., Gotoh, N., Ugi, S., & Maegawa, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061282 · Cited by 22
Systemic expression of genes related to inflammation and lipid metabolism in patients with dyslipidemia, type 2 diabetes mellitus and chronic periodontitis
Nepomuceno, R., Vallerini, B. D. F., da Silva, R. L., Corbi, S. C. T., Bastos, A. D. S., dos Santos, R. A., Takahashi, C. S., Orrico, S. R. P., & Scarel‐Caminaga, R. M. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.003 · Cited by 19
The pathophysiology of lipid metabolism and diabetes
Rivellese, A. A., Vaccaro, O., & Patti, L. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00332.x · Cited by 19
Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes
Russo, G. T., Horvath, K. V., Benedetto, A. D., Giandalia, A., Cucinotta, D., & Asztalos, B. F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.011 · Cited by 19
Trafficking and partitioning of fatty acids: the transition from fasted to fed state
Hodson, L., & Fielding, B. A. (2010) · Clinical Lipidology · doi:10.2217/clp.09.72 · Cited by 22
Increased blood cholesterol after a high saturated fat diet is prevented by aerobic exercise training
ORTEGA, J. F., Fernández-Elías, V. E., Hamouti, N., & Mora‐Rodríguez, R. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0123 · Cited by 20
Baseline Very Low-Density Lipoprotein Cholesterol is Associated with the Magnitude of Triglyceride Lowering on Statins, Fenofibric Acid, or Their Combination in Patients with Mixed Dyslipidemia
Sharma, A., Joshi, P. H., Rinehart, S. J., Thakker, K. M., Lele, A., & Vörös, S. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9559-3 · Cited by 18
Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels
Nishimura, M., Yamamoto, H., Yoshida, T., Seimiya, M., Sawabe, Y., Matsushita, K., Umemura, H., Sogawa, K., Takizawa, H., Yokosuka, O., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017309 · Cited by 18
Metabolism and Disposition of 14C-Labeled Peliglitazar in Humans
Wang, L., Munsick, C., Chen, S., Bonacorsi, S. J., Cheng, P. T. W., Humphreys, W. G., & Zhang, D. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035089 · Cited by 18
Association between non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular-kidney-metabolic syndrome: evidence from NHANES 2001–2018
Duan, Y., Yang, K., Zhang, T., Guo, X., Yin, Q., & Liu, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1548851 · Cited by 18
Triglycerides: How Much Credit Do They Deserve?
Kohli, P., & Cannon, C. P. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.11.006 · Cited by 17
The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis
Lin, T., Xia, X., Yu, J., Qiu, Y., Yi, C., Lin, J., Mao, H., Yang, X., & Huang, F. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01240-8 · Cited by 16
Cross talk between complete blood count and progression of type II diabetes mellitus
Narjis, M., Noreen, M., Safi, S. Z., Ilahi, N. E., Alomar, S. Y., & ALKHURIJI, A. F. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101492 · Cited by 17
Effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: A review.
Ebrahimian, Z., Razavi, B. M., Shaegh, S. A. M., & Hosseinzadeh, H. (2022) · PubMed Central · doi:10.22038/ijbms.2022.63264.13967 · Cited by 17
Atherogenic Dyslipidemia and Combination Pharmacotherapy in Diabetes: Recent Clinical Trials
Hamilton, S. J., & Watts, G. F. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.191 · Cited by 16
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2
Jukema, J. W., Chiang, C.-W., Ferrières, J., Santos, R. D., Verdejo, J., Waters, D. D., Messig, M., Tarasenko, L. C., & on behalf of the L-TAP 2 Investigators (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.522490 · Cited by 17
Antihyperglycemic and antioxidant activities of polysaccharide produced from Pleurotus ferulae in streptozotocin-induced diabetic rats
Choi, D., Piao, Y., Yu, S.-J., Lee, Y.-W., Lim, D.-H., Chang, Y., Park, S., Lee, M. K., Cha, W.-S., You, D.-S., et al. (2016) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-016-0007-8 · Cited by 17
The Activity of Serum 8-Iso-Prostaglandin F2α as Oxidative Stress Marker in Patients with Diabetes Mellitus Type 2 and Associated Dyslipidemic Hyperglycemia
Mukhtar, M. H., El-Emshaty, H. M., Al-Amodi, H. S. A. B., & Nasif, W. A. (2016) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2016.64033 · Cited by 17
Interventions in type 2 diabetes mellitus and cardiovascular mortality–An overview of clinical trials
Burggraaf, B., & Cabezas, M. C. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.04.017 · Cited by 17
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties
Theodosis‐Nobelos, P., Athanasekou, C. P., & Rekka, E. A. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.09.054 · Cited by 17
Hypoglycemic and hypolipidemic effects of samnamul (shoot of Aruncus dioicus var. kamtschaticus Hara) in mice fed a high-fat/high-sucrose diet
Kim, J.-I., Yun, J.-A., Jeong, Y.-K., & Baek, H.-J. (2018) · Food Science and Biotechnology · doi:10.1007/s10068-018-0390-5 · Cited by 17
Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes
Tomlinson, B., Chan, P., & Lam, C. W. K. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1750949 · Cited by 20
Unfavorable Triglyceride-rich Particle Profile in Subclinical Thyroid Disease: A Cross-sectional Analysis of ELSA-Brasil
Janovsky, C. C. P. S., Bittencourt, M. S., Goulart, A. C., Santos, R. D., Blaha, M. J., Jones, S. R., Toth, P. P., Lotufo, P. A., & Benseñor, I. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa205 · Cited by 18
Based on urine metabolomics to study the mechanism of Qi-deficiency affecting type 2 diabetes rats using ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry
Gao, Y., Wu, Y., Liu, Z., Fu, J., Zhang, Y., Wu, J., Liu, S., Song, F., & Liu, Z. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122850 · Cited by 16
A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes
Liu, H., Zhang, C., Song, F., Xiao, T., Meng, J., Zhang, Q., Liang, C.-L., Li, S., Wang, J., Zhang, B., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223107 · Cited by 16
Using Metabolomics in Diabetes Management with Traditional Chinese Medicine: A Review
He, Y., Zhang, H., Yang, Y., Yu, X., Zhang, X. L., Xing, Q., & Zhang, G. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500865 · Cited by 16
Impact of metabolic abnormalities for beta cell function: Clinical significance and underlying mechanisms
Grill, V., & BJORKLUND, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.009 · Cited by 16
Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids
Brackenridge, A., Jackson, N., Jefferson, W., Stolinski, M., Shojaee‐Moradie, F., Hovorka, R., Umpleby, A. M., & Russell-Jones, D. L. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02729.x · Cited by 15
Low normal thyroid function as a determinant of increased large very low density lipoprotein particles
van Tienhoven‐Wind, L. J. N., & Dullaart, R. P. F. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.015 · Cited by 15
Paraoxonase 1 Activity in Chylomicrons and VLDL: The Effect of Type 2 Diabetes and Meals Rich in Saturated Fat and Oleic Acid
Manning, P. J., de Jong, S. A., Ryalls, A. R., & Sutherland, W. H. F. (2011) · Lipids · doi:10.1007/s11745-011-3640-3 · Cited by 16
Mechanisms by which Elevated Resistin Levels Accelerate Atherosclerotic Cardiovascular Disease
Rashid, S. (2013) · Rheumatology Current Research · doi:10.4172/2161-1149.1000115 · Cited by 18
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome
Ng, T. W. K., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2009) · Clinical Science · doi:10.1042/cs20090110 · Cited by 17
Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model
Choi, H., Kim, Y.-S., Lee, H.-J., & Cheon, H. G. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174011 · Cited by 15
Association Between Remnant Cholesterol and Risk of Hyperuricemia: A Cross-Sectional Study
Wang, Z., Wu, M., Yan, H., Zhong, S., Xu, R., Zhao, Z., & Yang, Q.-C. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2299-2914 · Cited by 15
Dislipemia en población diabética tratada con estatinas. Resultados del estudio DYSIS en España
Millán, J., Alegría, E., Guijarro, C., Lozano, J. V., Vitale, G. C., González-Timón, B., & González‐Juanatey, J. R. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.09.030 · Cited by 15
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia
Kimura, Y., Tamasawa, N., Matsumura, K., Murakami, H., Yamashita, M., Matsuki, K., Tanabe, J., Murakami, H., Matsui, J., & Daimon, M. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33670 · Cited by 15
Iron Status Biomarkers and Cardiovascular Risk
Vaquero, M. P., García-Quismondo, Á., Cañizo, F. J., & Sánchez-Muniz, F. J. (2017) · InTech eBooks · doi:10.5772/intechopen.69040 · Cited by 15
Low serum LDL cholesterol in patients with type 2 diabetes
Saely, C. H., Eber, B., Pfeiffer, K. P., & Drexel, H. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.04.048 · Cited by 15
Effects of Pravastatin and Atorvastatin on HDL Cholesterol and Glucose Metabolism in Patients with Dyslipidemia and Glucose Intolerance: The PRAT Study
Sasaki, J., Otonari, T., Uchida, Y., Ikeda, Y., Biro, S., & Kono, S. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13532 · Cited by 15
Less than 50% of variation in HDL cholesterol between and within individuals, is explained by established predictors
Jeffs, J. A. R., Godsland, I. F., & Johnston, D. G. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.032 · Cited by 15
Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study
Mo, Z., Han, Y. Y., Cao, C., Huang, Q., Hu, Y., Yu, Z., & Hu, H. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01237-0 · Cited by 15
Triglyceride-lowering trials
KEECH, A. C., & Jenkins, A. J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000465 · Cited by 14
Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes
Soliman, H. M. A. L., & Ibrahim, A. (2021) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-021-00067-x · Cited by 14
Emerging Applications of Metabolomics to Assess the Efficacy of Traditional Chinese Medicines for Treating Type 2 Diabetes Mellitus
Zhang, Y., Yang, Y., Ding, L., Wang, Z., Xiao, Y., & Xiao, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735410 · Cited by 14
Toxicological assessment of the methanolic leaf extract of Bridelia ferrugelia
Owoade, A. O., Adetutu, A., Airaodion, A. I., & Ogundipe, O. O. (2018) · The Journal of Phytopharmacology · doi:10.31254/phyto.2018.7503 · Cited by 14
Gender differences in the relationship between plasma lipids and fasting plasma glucose in non-diabetic urban Chinese population: a cross-section study
Zheng, J., Gao, Y., Yuejuan, J., Zhou, X., Shi, Y., Li, Y., Wang, L., Wang, R., Li, M., Xiao, C., et al. (2014) · Frontiers of Medicine · doi:10.1007/s11684-014-0346-y · Cited by 14
Studies of a genetic variant in HK1 in relation to quantitative metabolic traits and to the prevalence of type 2 diabetes
Gjesing, A. P., Nielsen, A. A., Brandslund, I., Christensen, C., Sandbæk, A., Jørgensen, T., Witte, D. R., Bonnefond, A., Froguel, P., Hansen, T. F., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-99 · Cited by 14
A novel peroxisome proliferator–activated receptor α/γ dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys
Ding, S.-Y., Tigno, X. T., Braileanu, G., Ito, K., & HANSEN, B. C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.05.019 · Cited by 14
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · PubMed Central · Cited by 15
Nutrient determinants of postprandial triglyceride response in a population-based sample of type II diabetic patients
Rivellese, A. A., Iovine, C., Ciano, O., Costagliola, L., Galasso, R., Riccardi, G., & Vaccaro, O. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602432 · Cited by 14
Erythrocyte-derived measures of membrane lipid composition in healthy men: associations with arachidonic acid at low to moderate but not high insulin sensitivity
Felton, C. V., Stevenson, J. C., & Godsland, I. F. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.005 · Cited by 15
Fasting apoprotein B-48 level and coronary artery disease in a population without frank fasting hypertriglyceridemia
Valéro, R., Lorec, A., Paganelli, F. F., Béliard, S., Atlan, C., Lairon, D., Vialettes, B., & Portugal, H. (2005) · Metabolism · doi:10.1016/j.metabol.2005.05.008 · Cited by 14
Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes
Gao, H., Xie, C., Wang, H., Yu-jing, L. I. N., & Hong, T. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00534.x · Cited by 13
Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies
Shin, K., & Choi, H. D. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00516-3 · Cited by 13
Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and network meta‐analysis of randomized controlled trials
Zheng, H., Sigal, R. J., Coyle, D., Bai, Z., Johnston, A., Elliott, J., Hsieh, S., Kelly, S., Chen, L., Skidmore, B., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3515 · Cited by 13
Proteomic profiling of intestinal prechylomicron transport vesicle (PCTV)-associated proteins in an animal model of insulin resistance (94 char)
Wong, D. M., Webb, J. P., Malinowski, P. M., Xu, E., Macri, J., & Adeli, K. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.01.010 · Cited by 14
Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study
Alssema, M., El-Harchaoui, K., Schindhelm, R. K., Diamant, M., Nijpels, G., Kostense, P. J., Teerlink, T., Heine, R. J., Dallinga‐Thie, G. M., Kuivenhoven, J. A., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.002 · Cited by 13
Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type‐2 diabetes mellitus
Lund, S. S., Petersen, M., Frandsen, M., Smidt, U., Parving, H. ‐., Vaag, A. A., & Jensen, T. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510801995736 · Cited by 13
Dyslipidemia therapy update: the importance of full lipid profile assessment
Menown, I. B. A., Murtagh, G., Maher, V. M. G., Cooney, M. T., Graham, I. M., & TOMKIN, G. H. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0052-3 · Cited by 14
The Effect of PPARγ-Agonism on LDL Subclass Profile in Patients with Type 2 Diabetes and Coronary Artery Disease
Läutamaki, R., Nuutila, P., Airaksinen, J. K. E., Leino, A. E., Hiekkanen, H., Turiceanu, M., Stewart, M. W., Knuuti, J. M., & Rönnemaa, T. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.31 · Cited by 13
Impact of thiazolidinedione therapy on atherogenesis
van Wijk, J. P. H., & Rabelink, T. J. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0049-6 · Cited by 13
ANGPTL3 is a novel HDL component that regulates HDL function
Yang, L., Wang, Y., Xu, Y., Li, K., Yin, R., Zhang, L., Wang, D., Wei, L., Lang, J., Cheng, Y., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05032-x · Cited by 13
Lipoprotein glycation in atherogenesis
Younis, N. N., Soran, H., Sharma, R., Charlton-Menys, V., & Durrington, P. N. (2009) · Clinical Lipidology · doi:10.2217/clp.09.61 · Cited by 12
Effect of niacin on triglyceride‐rich lipoprotein apolipoprotein B‐48 kinetics in statin‐treated patients with type 2 diabetes
Pang, J., Chan, D. C., Hamilton, S. J., Tenneti, V. S., Watts, G. F., & Barrett, P. H. R. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12622 · Cited by 12
Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese
Yang, S., Li, S., Zhang, Y., Xu, R., Zhu, C.-G., Guo, Y., Wu, N., Qing, P., Gao, Y., Cui, C.-J., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0433-9 · Cited by 12
Treating Dyslipidemia in Type 2 Diabetes
Nelson, A. J., & Nicholls, S. J. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.005 · Cited by 13
Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ- db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway
You, H. N., Park, M. H., Hwang, S. Y., & Han, J.-S. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4015 · Cited by 12
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care
Bestehorn, K. P., Smolka, W., Pittrow, D., Schulte, H., & Assmann, G. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.532088 · Cited by 12
A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways
Aronis, K. N., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.001 · Cited by 12
Suppression of Type-II Diabetes with Dyslipidemia and Nephropathy by Peels of Musa cavendish Fruit
Navghare, V. V., & Dhawale, S. C. (2016) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-016-0548-y · Cited by 12
How can we prevent cardiovascular disease in diabetes
Wiklund, O., Håversen, L., Pettersson, C., & Hultén, L. M. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01828.x · Cited by 12
Improving macrovascular outcomes in type 2 diabetes: outcome studies in cardiovascular risk and metabolic control
Schneider, C. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112723 · Cited by 15
The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer
Vadlakonda, L., Indracanti, M., Kalangi, S. K., Gayatri, B. M., Gajula, N. N., & Reddy, A. B. M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00566-5 · Cited by 11
Association of remnant cholesterol and newly diagnosed early‐onset type 2 diabetes mellitus in Chinese population: A retrospective cross‐sectional study
Dong, W., Yan, S., Chen, H., Zhao, J., Zhang, Z., & Gu, W. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13498 · Cited by 10
Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study
Wu, D., Chen, G., Lan, Y., Chen, S., Ding, X., Wei, C., Balmer, L. A., Wang, W., Wu, S., & Xu, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04895-4 · Cited by 11
Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient
Watts, G. F., & Karpe, F. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.204990rep · Cited by 12
Mechanisms of Incretin Effects on Plasma Lipids and Implications for the Cardiovascular System
Xiao, C., Dash, S., & Lewis, G. F. (2012) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152512803530315 · Cited by 11
Skipping Breakfast Is Associated with an Atherogenic Lipid Profile in Overweight and Obese Prepubertal Children
Blasetti, A., Franchini, S., Castorani, V., Comegna, L., Fornari, E., Daniele, F., Prezioso, G., Piona, C. A., Federico, V., Zona, D. C., et al. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1849274 · Cited by 11
Particle numbers of lipoprotein subclasses and arterial stiffness among middle-aged men from the ERA JUMP study
Vishnu, A., Choo, J., Masaki, K., Mackey, R. H., Barinas‐Mitchell, E., Shin, C., Willcox, B. J., El‐Saed, A., Seto, T. B., Fujiyoshi, A., et al. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.60 · Cited by 11
Third Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2006) · Diabetes Care · doi:10.2337/dc06-zb07 · Cited by 11
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
Adiels, M., Mardinoğlu, A., Taskinen, M., & Borén, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00342 · Cited by 13
Self-citation
The Lipid Droplet: a Dynamic Organelle, not only Involved in the Storage and Turnover of Lipids
Olofsson, S., Boström, P., Lagerstedt, J. O., Andersson, L. K., Adiels, M., Perman, J., Rutberg, M., Li, L., & Borén, J. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_1 · Cited by 11
Chronic Inflammation in the Metabolic Syndrome: Emphasis on Adipose Tissue
Monteiro, R. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9701-0_4 · Cited by 11
Diabetic dyslipidemia and the metabolic syndrome
Cefalu, W. T. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.001 · Cited by 12
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb09 · Cited by 11
Plasma calprotectin as inflammation marker in pregnancies complicated by diabetes mellitus and superimposed preeclampsia
Sugulle, M., Kvehaugen, A. S., Brække, K., Harsem, N. K., & Staff, A. C. (2011) · Pregnancy Hypertension · doi:10.1016/j.preghy.2011.02.001 · Cited by 11
Padina arborescens Ameliorates Hyperglycemia and Dyslipidemia in C57BL/KsJ- db/db Mice, a Model of Type 2 Diabetes Mellitus
Park, M. H., & Han, J.-S. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3375 · Cited by 11
Antidyslipidemic and Antioxidant Activities of Matricaria pubescens (Desf.) Shultz. in Streptozotocin-Induced Diabetic Rats
Amssayef, A., Azzaoui, B. E., Ajebli, M., & Eddouks, M. (2020) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525718666200506100139 · Cited by 11
Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.
Bevilacqua, M., Guazzini, B., Righini, V., Barrella, M., Toscano, R., & Chebat, E. (2004) · Current Therapeutic Research · doi:10.1016/j.curtheres.2004.06.004 · Cited by 14
Whither the Lipid Profile: Feast, Famine, or No Free Lunch?
Watts, G. F., & Cohn, J. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.160093 · Cited by 10
Impact of Imperata Cylindrica polysaccharide on liver lipid metabolism disorders caused by hyperuricemia
Yu, W., Wang, J., Xiong, Y. B., Liu, J., Baranenko, D., Cifuentes, A., Ibáñez, E., Zhang, Y., & Lu, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137592 · Cited by 10
Age-Related Changes in Lipid and Glucose Levels Associated with Drug Use and Mortality: An Observational Study
Markovič, R., Grubelnik, V., Vošner, H. B., Kokol, P., Završnik, M., Janša, K., Zupet, M., Završnik, J., & Marhl, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020280 · Cited by 13
Interleukin-1-Beta and Dyslipidemic Syndrome as Major Risk Factors for Thrombotic Complications in Type 2 Diabetes Mellitus
Bădulescu, O. V., Badescu, C. M., Ciocoiu, M., & Bădescu, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/169420 · Cited by 10
The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL
van Dijk, P. R., Abdulle, A. E., Bulthuis, M. L. C., Perton, F. G., Connelly, M. A., van Goor, H., & Dullaart, R. P. F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010049 · Cited by 10
Protein Arginine Methyltransferase 4 Regulates Adipose Tissue Lipolysis in Type 1 Diabetic Mice
Li, Y., Peng, M., Zeng, T., Zheng, J., Liao, Y., Zhang, H., Yang, S., & Chen, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s235869 · Cited by 10
Maternal‐fetal outcomes of exercise applied in rats with mild hyperglycemia after embryonic implantation
Soares, T. S., Moraes-Souza, R. Q., Carneiro, T. B., Araujo, V. K. S., Schavinski, A. Z., Gratão, T. B., Damasceno, D. C., & Volpato, G. T. (2020) · Birth Defects Research · doi:10.1002/bdr2.1818 · Cited by 10
Comparative study on fasting and postprandial lipid profile in type 2 diabetes mellitus
Chahal, J., Gupta, S., Chawla, S. S., & Grewal, H. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1632_20 · Cited by 10

Authors: Taskinen, M.-R.
Affiliations: University of Helsinki (FI)
Corresponding author: Taskinen, M.-R.
ORCID: Taskinen, M.-R.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-06-01
Volume: 46
Issue: 6
Pages: 733-749
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1111-y
OpenAlex: W2020659754
Cited by: 888
References: 183
Citations by year: 2026: 27 · 2025: 37 · 2024: 32 · 2023: 36 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 29 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 42
FWCI: 6.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Academy of Finland
Diabetesliitto
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: diabetic dyslipidemia, type 2 diabetes, small dense LDL, triglyceride-rich lipoproteins, VLDL assembly, hepatic lipid metabolism, insulin signaling, PI3-kinase, SREBP-1c, de novo lipogenesis, apolipoprotein B-100, peroxisome proliferator-activated receptors, SREBP1, liver X receptor
MeSH terms: Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Diabetes Complications, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic dyslipidaemia: from basic research to clinical practice*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks